欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子抑制剂 > Proteases/Proteasome > Anagliptin

浏览历史

S86368

Anagliptin

源叶(MedMol) 97%
  • 英文名:
  • Anagliptin
  • 别名:
  • 阿拉格列汀;阿拉格列汀原料药;阿拉格列汀系列杂质;阿拉格列汀杂;阿拉格列汀(盐酸盐);Anagliptin;N-[2-[[2-[(2S)-2-cyano-1-pyrrolidinyl]-2-oxoethyl]aMino]-2-Methylpropyl]-2-Methyl-6-pyrazolo[1,5-a]pyriMidinecarboxaMide;Anagliptin API;Suiny;(S)-
  • CAS号:
  • 739366-20-2
  • 分子式:
  • C19H25N7O2
  • 分子量:
  • 383.4475
品牌货号产品规格价格(RMB) 库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
源叶(MedMol) S86368-5mg 97% ¥1172.00元 10 - - - EA 加入购物车
源叶(MedMol) S86368-25mg 97% ¥4288.00元 9 - - - EA 加入购物车
源叶(MedMol) S86368-50mg 97% ¥7724.00元 8 - - - EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献

质检证书(COA)

摩尔浓度计算器

相关产品

  • 产品描述: Anagliptin (SK-0403) is a highly selective, potent, orally active inhibitor of dipeptidyl peptidase 4 (DPP-4), with an IC50 of 3.8 nM, and less selective at DPP-8 and DDP-9 with IC50s of 68 nM and 60 nM, respectively[1]
  • 靶点: DPP-4:3.8 nM (IC50);DPP-9:60 nM (IC50);DPP-8:68 nM (IC50);Proteasome;DPP-4
  • 体内研究:
    Anagliptin (SK-0403) (0.3%; in diet; 16 weeks) reduces atherosclerotic lesion and does not increase the number of circulating EPCs in apoliporotein E (apoE)-deficient mice. Anagliptin (0.3%; in diet; 4 weeks) exhibits a lipid‐lowering effect in a hyperlipidemic mice model. Animal Model: Male apoliporotein E (apoE)-deficient mice Dosage: 0.3% Administration: In diet, 16 weeks Result: Reduced DPP-4 activity in the plasma as expected and did not affect food consumption or body weight gain. Significantly reduced total cholesterol level, especially VLDL and LDL-C without affecting triglyceride level. Also decreased the α-SMA-positive area within the individual plaque.
  • 参考文献:
    1. Kato N, et al. Discovery and pharmacological characterization of N-[2-({2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide hydrochloride (anagliptin hydrochloride salt) as a potent and selective DPP-IV inhibitor. Bioorg Med Chem. 2011 Dec 1;19(23):7221-7. 2. Ervinna N, et al. Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice. Endocrinology. 2013 Mar;154(3):1260-70. 3. Yano W, et al. Mechanism of lipid-lowering action of the dipeptidyl peptidase-4 inhibitor, anagliptin, in low-density lipoprotein receptor-deficient mice. J Diabetes Investig. 2017 Mar;8(2):155-160.
  • 溶解性: Soluble  in  DMSO
  • 保存条件: -20℃
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 2.608 ml 13.04 ml 26.079 ml
    5 mM 0.522 ml 2.608 ml 5.216 ml
    10 mM 0.261 ml 1.304 ml 2.608 ml
    50 mM 0.052 ml 0.261 ml 0.522 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。